ClinicalTrials.Veeva

Menu

A Web Site and Print Materials Intervention for Smoking Intervention for Childhood and Young Adult Cancer Survivors (PFH2)

Dana-Farber Cancer Institute logo

Dana-Farber Cancer Institute

Status

Completed

Conditions

Cancer

Treatments

Behavioral: print materials
Other: Web Intervention

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00588107
R01CA106914 (U.S. NIH Grant/Contract)
05-032

Details and patient eligibility

About

The purpose of this study was to compare two different ways of helping people who have had childhood cancer, leukemia, tumors or similar illnesses learn health information and information about trying to quit smoking. All participants received materials in the mail about their health, survivorship, and smoking. Some participants were also invited to use a website. The goal of the study was to see which is a better way to get information about health issues, survivorship, and smoking.

Full description

The study was a randomized controlled trial with two groups. It was designed to demonstrate the efficacy and cost-effectiveness of a Web-based format of the PFH intervention, compared to a written Materials control condition. The study was conducted among childhood and young adult cancer survivors, who smoke, at four survivor clinics. Participants in both conditions received access to pharmacotherapy at no cost. Participants in the Web condition received access to an interactive Web site that focuses on survivorship, health, and smoking.

Participants in the Web condition received access to an interactive Web site that focuses on survivorship, health, and smoking. Participants in the Materials control group received tailored and targeted print materials.

Enrollment

374 patients

Sex

All

Ages

18 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Have been diagnosed with cancer before age 35
  • Currently be ≥ 18 years of age and ≤ 55 years of age
  • 2 or more years out of cancer treatment
  • Be mentally capable of providing informed consent
  • Be reachable by telephone for screening and survey completion
  • Be a current smoker (defined as having taken one puff of a cigarette in the last 30 days)
  • Fluent in English

Exclusion criteria

  • Currently undergoing active treatment for cancer

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

374 participants in 2 patient groups

Web site access
Experimental group
Description:
Web intervention- and access to pharmacotherapy
Treatment:
Other: Web Intervention
print materials
Active Comparator group
Description:
Receives tailored print materials and access to pharmacotherapy (Materials condition)
Treatment:
Behavioral: print materials

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems